NewsFlash »

NCI Discovery May Be Used Toward Cancer Vaccine Development – On June 8 the National Cancer Institute (NCI) announced that it had determined the structure of thin fibers that are commonly found on the surface of a type of E. coli bacteria responsible for traveler’s diarrhea. The researchers, who work in NCI’s Center for Cancer Research, employed atomic resolution technology to determine how the fibers assemble upon exit from the cells through a pore on the bacterial surface. Knowledge of this mechanism is currently being used to develop a vaccine for traveler’s diarrhea, although it may also be used later on for cancer vaccine development and cancer cell motility studies. For more information on the study, please read the NCI press release.

Sail-A-Thon – The Leukemia & Lymphoma Society (LLS) is sponsoring a sailing fundraiser for children and young adults on June 25 at the Fishing Bay Yacht Club in Deltaville, VA. The LLS will collect donations based on the number of laps that participants sail around the course. For more information, please visit the LLS Web site.

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.

NewsFlash »

20th Annual Gelatin Splash – On June 11 the Leukemia & Lymphoma Society (LLS) is holding an event to raise money for blood cancer research and patient aid services. The event will be held at Banchetti by Rizzo’s in Amherst, NY and will take place from 6 p.m. to 9 p.m. In the past 19 years, the LLS has raised over $1.4 million from this event. If participating in the gelatin splash, the suggested minimum of sponsorship money is $300. If attending without participating in the gelatin splash, admission is free. For more information, please visit the LLS Web site.

Institutional Insights In Multiple Myeloma – On June 18 the Multiple Myeloma Research Foundation (MMRF) is sponsoring an educational program at the Hilton Chicago. Registration begins at 10:30 a.m., and the program lasts from 11 a.m. to 2 p.m. This program’s topics include frontline therapy, stem cell transplant, relapsed/refractory disease, supportive care, and clinical trials. Time will also be allowed for a question and answer session. For more information, please visit the MMRF Web site.

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.

NewsFlash »

MMRF Race For Research : Tri-State – The Multiple Myeloma Research Foundation (MMRF) is sponsoring a 5K race on June 7 at the New Canaan High School, in New Canaan, CT.  Registration begins at 7:30 a.m. and the race start time is 9 a.m.  For more information or to register, please visit the MMRF Race for Research Web site.

Emerging Therapies In Leukemia, Lymphoma And Myeloma – On June 16, a free educational teleconference focusing on these three diseases begins at noon and ends at 1:30 p.m. Eastern Time. Medical professionals who will speak include Gail J. Roboz, MD; John P. Leonard, MD; and Robert Z. Orlowski, MD, PhD. Questions are welcome during the presentation. For more information or to register, please visit The Leukemia & Lymphoma Society Web site.

For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.

News»

NewsFlash »

Intas Pharmaceuticals To Market Bortezomib In India – Intas Biopharmaceuticals has recently launched Borviz (bortezomib) in India for the treatment of multiple myeloma. Bortezomib is marketed in the U.S. under the brand name Velcade. The medication is given as an intravenous injection, and the dosage is based on individual medical conditions. About 3.5 million cancer cases have been diagnosed in India and statistics show that the age of onset for multiple myeloma is decreasing from the current 65 years of age. For more information about Borviz see the India PR Wire press release.

Myeloma: Understanding Drug Therapy And Stem Cell Transplantation – The Leukemia & Lymphoma Society (LLS) is sponsoring this free teleconference on May 14 from noon to 1:30 p.m. EST. Dr. Seema Singhal, Professor of Medicine and Director of the Myeloma Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, will present on the topic and take questions from participants. For more information, please visit the LLS Web site.

Honolulu Triathlon – On May 17, members of the Leukemia & Lymphoma Society’s (LLS) Team In Training program will participate in this Hawaiian triathlon. There will be both international and sprint races. For more information, please visit the LLS Web site.

NewsFlash »

2009 BIO International Convention – This convention will be held from May 18 to May 21 in Atlanta, GA. Over 180 companies will visit and give presentations on their developments in technologies and other accomplishments. The convention is meant to act as a partnering tool for companies, as well as to give licensing tips and develop industry resources. For more information or to register, please visit the official BIO International Convention Web site.

2009 ASCO Meeting – The American Society of Clinical Oncology (ASCO) meeting will be held May 29 to June 2 in Orlando, FL. This meeting will include forums and exhibits on recent scientific and educational progress in oncology. A major focus at the meeting will be on personalizing health care. Registration and a registration fee are required. For more information or to register, please visit the ASCO Web site.

7th Annual Monte Carlo Night – This night of entertainment will be held on May 14 in San Francisco City Hall. The event begins at 7 p.m. and ends at 1 a.m. Proceeds from the event will benefit the Leukemia and Lymphoma Society (LLS). The price of tickets is $75. For more information, please visit the LLS Web site.

What Myeloma Patients Should Know About The Swine Flu – The Leukemia and Lymphoma Society (LLS) has compiled a list of need-to-know information about the H1N1 flu (swine flu) for patients with chronic medical conditions or those with weakened immune systems. To view this list, please visit the LLS Web site.

For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.

NewsFlash »

MMRF ‘Laugh For Life’ Fundraising Event — On May 5, the Multiple Myeloma Research Foundation (MMRF) will host the ‘Laugh For Life’ fundraiser in New York City from 6 p.m. to 9 p.m.  The event will feature dinner, live and silent auctions, and an entertaining line up of stand-up comedians.  More information, as well as ticket purchase, may be found at the MMRF Web site.

Dacetuzumab Clinical Trials Currently Enrolling — Seattle Genetics, Inc. has announced preclinical data for dacetuzumab, an anti-CD40 monoclonal antibody currently being tested for treatment of multiple myeloma and non-Hodgkin's lymphoma. In the most recent results, dacetuzumab enhanced patient response to regimens of conventional chemotherapeutic agents, and researchers have identified a tumor mutation that helps predict which patients will respond to dacetuzumab. Two clinical trials, the first testing dacetuzumab alone and the second testing it in conjunction with Revlimid (lenalidomide) and dexamethasone (Decadron), are currently enrolling. For more information, see the Seattle Genetics, Inc. preclinical results press release.

Sign Up With LLS’s 'Team In Training' For The Nation’s Triathlon – On September 13, the Leukemia & Lymphoma Society (LLS) will host the Nation’s Triathlon, the only triathlon dedicated to fighting blood cancer, in Washington, D.C.  Although the event is already sold out, individuals can still participate by joining LLS’s 'Team in Training' (TNT) program. By signing up with TNT, participants will receive four to five months of certified coaching, race gear, and travel and lodging arrangements. For more information, see the LLS Team in Training Web site.

For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.